Singapore, Sept. 19 -- BCAL Diagnostics has entered into an exclusive licence agreement with ClearNote Health Inc., a US-based precision diagnostics startup, for the distribution of ClearNote Health's pancreatic and ovarian cancer blood tests in Australia and New Zealand (NZ).
Published by HT Digital Content Services with permission from BioSpectrum Asia....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.